van Winden, T. M.S.Klumper, J.Kleinrouweler, C. E.Tichelaar, M. A.Naaktgeboren, C. A.Nijman, T. A.van Baar, A. L.van Wassenaer-Leemhuis, A. G.Roseboom, T. J.van’t Hooft, J.Roos, C.Mol, B. W.Pajkrt, E.Oudijk, M. A.2020-07-202020-07-202020-08van Winden, T M S, Klumper, J, Kleinrouweler, C E, Tichelaar, M A, Naaktgeboren, C A, Nijman, T A, van Baar, A L, van Wassenaer-Leemhuis, A G, Roseboom, T J, van’t Hooft, J, Roos, C, Mol, B W, Pajkrt, E & Oudijk, M A 2020, 'Effects of tocolysis with nifedipine or atosiban on child outcome : follow-up of the APOSTEL III trial', BJOG: An International Journal of Obstetrics and Gynaecology, vol. 127, no. 9, pp. 1129-1137. https://doi.org/10.1111/1471-0528.161861470-0328https://hdl.handle.net/2164/14741© 2020 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists.9302948engAtosibanbehaviourchilddevelopmentexecutive functionfollow-uphealthinfantneurodevelopmentnifedipinepreterm birthpreterm labourtocolysisANTIBIOTICSSPONTANEOUS PRETERM LABOROXYTOCINR MedicineObstetrics and GynaecologyREffects of tocolysis with nifedipine or atosiban on child outcome : follow-up of the APOSTEL III trialJournal article10.1111/1471-0528.16186http://www.scopus.com/inward/record.url?scp=85082492961&partnerID=8YFLogxK1279